The seed round closes. The product ships. Revenue climbs. Then the founder hits a wall.

It is not a product problem or a market problem. It is a capital problem, sitting squarely in the $10-million to $30-million range that defines a Series B round. For a growing number of BC founders, this stretch of the financing journey has become the most dangerous ground in the startup lifecycle.

Call it the Series B Desert.

While Vancouver’s early-stage infrastructure has strengthened—a recent wave of new seed funds has deepened the pre-Series A pipeline—the growth equity layer remains thin. Data from the Canadian Venture Capital & Private Equity Association shows that Canadian Series B deal counts and average round sizes trail US comparables by a significant margin. The province accounts for roughly 15 per cent of Canadian tech GDP but captures a disproportionately low share of growth-stage capital deployed nationally.

The consequences are compounding. Companies that cannot raise a Series B face difficult choices: cut headcount to extend runway, accept a premature acquisition at a sub-scale valuation, or relocate to markets with deeper capital pools, such as San Francisco, New York, or Toronto.

Where the money isn't

The structural problem has two sides. Canadian institutional funds—pension plans and insurance companies—remain under-allocated to growth equity relative to their US counterparts. While BDC Capital maintains a growth equity mandate, its deployment pace in BC has not kept up with the volume of companies reaching that stage.

Meanwhile, US crossover investors—late-stage growth vehicles and Silicon Valley firms that write $20-million cheques—largely bypass BC. US investors often prioritize Toronto due to its market size and direct flight paths from New York. Vancouver-based companies must work harder to secure the same attention.

CVCA regional data confirms this gravitational pull. Ontario captures the majority of Canadian growth-stage deals, leaving BC a distant second. This gap is driven by proximity, network density, and the path-of-least-resistance logic governing institutional capital.

The sectors hit hardest

The desert is not uniform. Mapping the gap by sector reveals where the pain—and the opportunity for contrarian investors—is concentrated.

SaaS and enterprise software: BC produces strong SaaS businesses, but the metrics prioritized by US growth investors—such as ARR above $5-million and net dollar retention exceeding 110 per cent—take longer to achieve in a smaller domestic market. By the time a BC SaaS company is ready for a Series B, it may have already fielded acquisition interest from a US strategic buyer, offering a clean exit at a valuation that, while below potential, is immediate.

Cleantech and climate tech: These companies face longer capital cycles and higher asset intensity. The patient capital required to bridge hardware-enabled businesses from Series A to growth equity is scarce in Canada. Innovate BC portfolio data highlights a cluster of climate-adjacent companies that have successfully raised Series A rounds but now face a gap with no obvious Canadian lead investor available at the growth stage.

Healthtech and medtech: Regulatory timelines extend the path to revenue, and the LP base that understands healthcare risk is thin in Canada. While Vancouver’s medtech cluster has scaled beyond pure software, the capital infrastructure has not kept pace with the science.

Founders from underrepresented backgrounds: The Series B is a relationship-driven round. Founders who are women, racialized, or outside the traditional tech-founder profile are statistically less likely to possess the established institutional network connections required at this stage.

What premature exits cost

Every acquisition of a BC company at a sub-scale valuation represents a transfer of economic value out of the province. A company acquired for $40-million because it could not raise a Series B might have reached a $200-million or $400-million valuation at maturity. The difference—in tax revenue, anchor employment, and the next generation of founders spinning out of a scaled company—is significant.

US acquirer activity in BC tech has been consistently elevated since 2023, targeting companies with real revenue and growth that simply lacked the capital to scale independently.

Navigating the gap

The gap is structural, but not impassable. Successful founders are reaching south earlier, engineering a US market presence—such as sales hires or customer bases—to become legible to the investor base that can write the necessary cheques. The pitch is shifting from "a Canadian company seeking a US investor" to "a North American company with a meaningful presence in both markets."

Founders are also utilizing revenue-based financing as a bridge instrument to extend runway and hit the metrics required for an institutional round without taking dilutive equity at an unfavourable moment.

Finally, founders are targeting investors who recognize this gap as an opportunity. Yaletown Partners, Pender Ventures, and OMERS Ventures remain active in the growth equity space, providing consistent sources of capital that understand the BC market.

The bigger picture

The Series B Desert is a market failure that can be addressed. The seed-stage gap that existed five years ago was mitigated through new fund formation, government co-investment, and ecosystem maturation. The growth-stage gap requires similar focus.

Policy levers include incentivizing institutional allocation to Canadian growth equity and expanding co-investment vehicles. For founders, the strategy is clear: build US investor relationships before they are needed, hit metrics to ensure the round is competitive, and identify local funds with the mandate and conviction to lead. The desert has water; the challenge is knowing where to dig.